QQ客服 官方微博 反馈留言

浏览/检索结果: 共18条，第1-10条 帮助 限定条件 发表日期：2020    专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Immune Checkpoint Blockade in Cancer Immunotherapy: Mechanisms, Clinical Outcomes, and Safety Profiles of PD-1/PD-L1 Inhibitors 期刊论文 ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020, 卷号: 68, 期号: 6, 页码: 15 作者:  Yan, Yan;  Zhang, Li;  Zuo, Yun;  Qian, Heya;  Liu, Chang 收藏  |  浏览/下载：19/0  |  提交时间：2021/05/24 Immune checkpoints  PD-1  PD-L1  Monoclonal antibody  Immunotherapy   Emerging roles of class I PI3K inhibitors in modulating tumor microenvironment and immunity 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 8 作者:  Sun, Pu;  Meng, Ling-hua 收藏  |  浏览/下载：39/0  |  提交时间：2020/12/21 phosphoinositide 3-kinase (PI3K)  PI3K inhibitors  tumor microenvironment  immune cells  immunotherapy   SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7 作者:  Xia, Zong-jun;  Ji, Yin-chun;  Sun, De-qiao;  Peng, Xia;  Gao, Ying-lei 收藏  |  浏览/下载：75/0  |  提交时间：2020/12/21 ROS1 kinase  ROS1 inhibitor  SAF-189s  lorlatinib  crizotinib resistance  G2032R mutant  NSCLC   Comparative Transcriptomic and Proteomic Analyses Prove that IFN-lambda 1 is a More Potent Inducer of ISGs than IFN-alpha against Porcine Epidemic Diarrhea Virus in Porcine Intestinal Epithelial Cells 期刊论文 JOURNAL OF PROTEOME RESEARCH, 2020, 卷号: 19, 期号: 9, 页码: 3697-3707 作者:  Zhao, Mingzhi;  Li, Liang;  Zhai, Linhui;  Yue, Qi;  Liu, Hongyu 收藏  |  浏览/下载：66/0  |  提交时间：2020/12/21 intestinal epithelial cell  IFN-lambda 1  IFN-alpha  anti-PEDV  transcriptomics  proteomics   Sulfation predominates the pharmacokinetics, metabolism, and excretion of forsythin in humans: major enzymes and transporters identified 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 12 作者:  Pan, Lu-lu;  Yang, Yong;  Hui, Min;  Wang, Shuo;  Li, Cui-yun 收藏  |  浏览/下载：82/0  |  提交时间：2020/12/24 forsythin  pharmacokinetics  drug metabolism  drug excretion  sulfation  glucuronidation  organic anion transporter 3   Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 10 作者:  Zhang, Xiao-tuan;  Hu, Xiao-bei;  Wang, Han-lin;  Kan, Wei-juan;  Xu, Lei 收藏  |  浏览/下载：49/0  |  提交时间：2020/12/24 DLBCL  BTK inhibitor  ibrutinib resistance  UPR  TUDCA  2-DG   The artemisinin analog SM934 alleviates dry eye disease in rodent models by regulating TLR4/NF-kappa B/NLRP3 signaling 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 11 作者:  Yang, Fang-ming;  Fan, Di;  Yang, Xiao-qian;  Zhu, Feng-hua;  Shao, Mei-juan 收藏  |  浏览/下载：26/0  |  提交时间：2020/12/24 dry eye disease  artemisinin derivative  beta-aminoarteether maleate  inflammation  macrophages  TLR4  inflammasome   Cancer nanomedicine meets immunotherapy: opportunities and challenges 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 7, 页码: 954-958 作者:  Sun, Qingxue;  Bai, Xiangyang;  Sofias, Alexandros Marios;  van der Meel, Roy;  Ruiz-Hernandez, Eduardo 收藏  |  浏览/下载：11/0  |  提交时间：2020/12/24 nanomedicine  immunotherapy  targeting  combination therapy  clinical translation   Species differences in the CYP3A-catalyzed metabolism of TPN729, a novel PDE5 inhibitor 期刊论文 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 9 作者:  Tian, Qian-qian;  Zhu, Yun-ting;  Diao, Xing-xing;  Zhang, Xiang-lei;  Xu, Ye-chun 收藏  |  浏览/下载：68/0  |  提交时间：2020/12/24 PDE5 inhibitor  TPN729  M3  species difference  pharmacokinetics  metabolite identification   Update of P2Y receptor pharmacology: IUPHAR Review 27 期刊论文 BRITISH JOURNAL OF PHARMACOLOGY, 2020, 卷号: 177, 期号: 11, 页码: 2413-2433 作者:  Jacobson, Kenneth A.;  Delicado, Esmerilda G.;  Gachet, Christian;  Kennedy, Charles;  von Kuegelgen, Ivar 收藏  |  浏览/下载：61/0  |  提交时间：2020/07/01